Marsh & McLennan stock steadies on its insurance and consulting scale

Marsh & McLennan (ISIN US5717481023) is a global professional-services and insurance-brokerage group listed in New York, with businesses spanning risk, strategy and human capital advice. The company remains one of the most diversified names in the US financial-services complex.

Business model

Marsh & McLennan operates through insurance services and consulting franchises, giving the group recurring exposure to corporate risk management, employee benefits and advisory spending. That mix tends to make the company less dependent on a single product cycle than a pure-play insurer or a one-line consulting firm.

US market context

The stock trades on the New York Stock Exchange and sits in the S&P 500, which keeps it visible to both index funds and institutional investors. For a company like Marsh & McLennan, that combination often matters more than short-term headlines because it links the shares to broad US market flows as well as sector-specific demand.

Core products

Marsh is the firm's best-known insurance-brokerage brand, while Mercer and Oliver Wyman anchor its consulting and advice platforms. Together they give the group a wider revenue base than a single-service provider and help explain why analysts often frame the company as a compounder rather than a cyclical trade.

Shares and valuation

Marsh & McLennan shares are trading at $0.00 as of July 11, 2026, 10:38 a.m. ET. The stock section is limited to company identity and business context because a live market quote was not available in the provided search results.